AbbVie Duodopa - User Manual

Important Risk Minimisation Information
Patient Pocket Guide
EDUCATIONAL MATERIAL FOR RISK MINIMISATION
Duodopa
®

Summary

The Duodopa System Overview

Daytime Treatment Guide

Morning Procedure Setup

Morning Procedure Connection

Administering a Morning Dose

Daily Dose Procedure

Evening Procedure and Flushing

Tube Mobilisation Procedure

Important Information and Warnings

Overdose and Missed Dose Guidance

Stopping or Lowering Duodopa Dose Safely

Common Tube Delivery System Complications

Troubleshooting Tube Blockages

Stoma Site Complications and Actions

Pump and Tube Side Effects

Very Common Complications List

About the Pump Overview

Operating the Pump: Morning Dose

Steps to switch on the pump and administer the morning dose.

Operating the Pump: Continuous Dose

Stopping and Turning Off the Pump

Pump Caution and Showering Advice

Showering Procedure Steps

Common Pump Alarms and Actions

Additional Pump Alarms and Actions

Further Pump Alarms and Actions

Reporting Side Effects to HPRA

AbbVie Duodopa Specifications

General

Generic Name	Levodopa and Carbidopa
Dosage Form	Intestinal gel
Active Ingredients	Levodopa and Carbidopa
Manufacturer	AbbVie
Delivery Method	Continuous intestinal infusion
Storage Conditions	Do not freeze.
Indication	Treatment of advanced Parkinson's disease with severe motor fluctuations and hyper-/dyskinesia
Administration	Administered directly into the small intestine through a percutaneous endoscopic gastrostomy with a jejunal extension tube (PEG-J)